One step closer: a COVID vaccine designed for long lasting immunity Experts say a new vaccine candidate targeting T cells is promising. So what could it mean for the global pandemic response?
Cheaper treatments for cancer, Parkinson’s and motor neurone patients Changes to the Pharmaceutical Benefits Scheme will see some patients saving up to $300,000 per year.